Author Guidelines

PEER REVIEW PROCESS
In the review process, Journal of Science and Technology Research for Pharmacy (JSTRP) involves writers, editors, section editors, and reviewers. Where in the review process, this Journal applies the Double-Blind Review model to maintain confidentiality. The editor first checks every script that is submitted, if the article meets the focus and scope and guidelines for writing this Journal, the manuscript is continued to the reviewer to review the content and novelty of the paper, if not then the article will be returned to the author. A minimum of two reviewers will examine each paper for three weeks with the criteria for evaluating the manuscript, as stated in the article rating form for reviewers.

TYPES OF PAPERS
Research articles: Research articles describe a highly significant advancement in any area of pharmaceutics, phytochemistry, pharmaceutical analysis, drug development, herbal technology, pharmacognosy, drug formulation, nanotechnology, novel drug delivery system, pharmacoinformatic, bioinformatics and synthetic chemistry research. All papers are judged according to originality, novelty, quality of scientific content and contribution to existing knowledge. There is no strict page limit, but we advise a maximum limited to 6000 words including references. Most importantly, paper length and content must be appropriate. Extensive tables, procedures, computer programs or animated graphics should be presented in form of Electronic Supplementary Material.
Review article: Reviews (up to 20 printed pages, approx. 12000 words including references) should address issues relevant to a wide readership and intelligible to non-specialists.

MANUSCRIPT SUBMISSION
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.

Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.

Online Submission
Please follow the hyperlink “Submit” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
The Editorial Office is automatically alerted by the system immediately after your manuscript has been received.
 If you face any problems using the electronic submission procedures or have any questions regarding the submission of your manuscript, please contact the Editorial: [email protected]

Authors using the system for the first time should follow the online instructions for setting up an author account. An ID and password will be e-mailed to new users. Co-authors should note that they have the responsibility to read and edit manuscripts bearing their name. After logging in, authors may submit a new manuscript, check the status of a manuscript under review or submit a revised version of their manuscript.

PREPARE SUPPORTING INFORMATION

Please make sure you have the following information available before you submit your manuscript:

Author information
Full names and email addresses of all co-authors on your manuscript.

Cover letter
A cover letter that includes the following information, as well as any additional information requested in the instructions for your specific article type:

• An explanation of why your manuscript should be published in Journal of Science and Technology Research for Pharmacy


• An explanation of any issues relating to journal policies


• A declaration of any potential competing interests


• Confirmation that all authors have approved the manuscript for submission


• Confirmation that the content of the manuscript has not been published, or submitted for publication elsewhere


• If you are submitting a manuscript to a particular special issue, please refer to its specific name in your covering letter

Peer reviewers
You may suggest potential peer reviewers for your manuscript. If you wish to do so, please provide institutional email addresses where possible, or information which will help the Editor to verify the identity of the reviewer (for example an ORCID or Scopus ID). Intentionally falsifying information, for example, suggesting reviewers with a false name or email address, will result in rejection of your manuscript and may lead to further investigation in line with our misconduct policy. A suggested reviewer from the author should be regulated by reviewer criteria.

Reviewer criteria
Qualified: Reviewers should typically hold a doctorate (PhD/MD/MBBS or equivalent). 
If possible, when a reviewer suggestion is rejected due to lack of qualifications, the editorial team will suggest that their Principal Investigator/Supervisor is invited instead, and the original person could then take the role of co-reviewer.
Expert: Reviewers should have published at least three articles indexed in scopus as lead author in a relevant topic, with at least one article having been published in the last five years. In fields where a reviewer’s expertise is not typically measured by their publication record or if the suggested reviewer’s expertise is demonstrable in ways other than their publication record, please provide an explanation of their suitability.
Impartial: Reviewers should not have any competing interests that can bias their assessment of the article – they should not be close collaborators of authors or be personally, associated with them.
We understand that in small/specialized fields of research, it may not be possible to suggest reviewers who have not collaborated with the authors; if that is the case, please contact the Editorial Team to discuss how best to proceed.

• Global:For any given article, we require that reviewers are from different institutions. (This does not apply to large, multi-site institutions, such as Max-Planck Institutes or University of California). We also strongly encourage authors to suggest geographically-diverse reviewers to gain an international perspective on the article. If all suggested reviewers are from the same institution or country, the Editorial Team may request that additional names of potential reviewers from different locations are provided.

If you feel that our standard reviewer criteria are not appropriate for your area of research please do not hesitate to get in touch, and we’ll be happy to discuss this with you.

Excluding peer reviewers
During submission you may enter details of anyone who you would prefer not to review your manuscript.

MANUSCRIPT PREPARATION
The manuscript should be typed, double-spaced on standard A4 sized paper (8.5" x 11") with 1" margins on all sides. Times New Roman font 12 pt should be used. The fonts used in the text, as well as graphics, should be restricted to Times New Roman.

File formats
The Microsoft word (.doc, .docx, .rtf) file formats are acceptable for the main manuscript document.
Please note: editable files are required for processing in production. If your manuscript contains any non-editable files (such as PDFs) you will be required to resubmit an editable file when you submit your revised manuscript, or after editorial acceptance in case, no revision is necessary.

Style and language
For editors and reviewers to accurately assess the work presented in your manuscript you need to ensure the English language is of sufficient quality to be understood. If you need help with writing in English you should consider:

• Visiting the English language tutorial which covers the common mistakes when writing in English.


• Asking a colleague who is a native English speaker to review your manuscript for clarity.


• Using a professional language editing service where editors will improve the English to ensure that your meaning is clear and identify problems that require your review.


• The author should use American style language.

Please note that the use of a language editing service is not a requirement for publication in the journal and does not imply or guarantee that the article will be selected for peer review or accepted. 
If you are not a native English speaker, it is advisable to have your manuscript checked/edited by a native speaker prior to submission. That will, eventually, provide clear language which will give the reviewers and editors the opportunity to concentrate on the scientific content of the paper.
This journal has well-defined policies for English language editing.
Authors are required to have their manuscripts edited by a native English speaker or professional English language editor BEFORE submission. Authors have to confirm by checking a tick box in the submission process that they have followed the above requirement:
"The text is checked by a native English speaker, or professional English language editor, duly acknowledged in the manuscript. I am aware that non-edited manuscripts could be rejected prior to peer-review"

Title page
The title page should contain a clear, concise, and informative title of the article followed by the names and affiliations of the authors. The affiliation should comprise the department, institution, city, state (or nation), and should be typed as a footnote to the author's name. The corresponding author should provides the 16-digit ORCID and must indicate his or her complete mailing address, office/cellular phone number, fax number, and email address at the lower left of the Title Page.

Article Structure
Abstract
The abstract should not be more than 250 words and should provide brief details about background which include objectives, material and methods, results and conclusions. The abstract should be structured, it should be a single paragraph with subheadings. The abstract must be followed by four-six keywords which can be used for indexing purposes.

Introduction
The Introduction section should explain the background to the study, its aims, a summary of the existing literature and why this study was necessary or its contribution to the field.

Materials and methods
Please provide concise but complete information about the material and the analytical, statistical, and experimental procedures used. This part should be as clear as possible to enable other scientists to repeat the research presented. The use of subheadings to divide the text is encouraged. In the case of animal/human experiments or clinical trials, authors must give the details of ethical approval.

Result
Data acquired from the research with the appropriate statistical analysis described in the methods section should be included in this section. In this part, the same data/ information given in a table must not be repeated in a figure or vice versa. Tables and Figures should be self-explanatory and it is not acceptable to repeat extensively the numerals from tables into text and give lengthy and unnecessary explanations of the Tables and Figures.

Discussion
The discussion should discuss the implications of the findings in the context of existing research and highlight the limitations of the study.

Conclusion
This should state clearly the main conclusions and provide an explanation of the importance and relevance of the study reported. Authors also should provide a further recommendation of the future study.

Acknowledgements
The names of funding organizations should be written in full. In addition, please provide the funding information in a separate step of the submission process in the peer review system. Funder names should preferably be selected from the standardized list you will see during submission. If the funding institution you need is not listed, it can be entered as free text. Funding information will be published as searchable metadata for the accepted article, whereas acknowledgements are published within the paper.

Conflict of Interest
Author A has received research grants from Company A. Author B has received a speaker honorarium from Company X and owns stock in Company Y. Author C is a member of committee Z. If no conflict exists, the authors should state: The authors declare that they have no conflict of interest.

Authors' contributions
The individual contributions of authors to the manuscript should be specified in this section.
Please use initials to refer to each author's contribution in this section, for example: "FC analyzed and interpreted the patient data. All authors read and approved the final manuscript."

References
References are numbered in consecutive order in the text, tables, or figures.
Use superscript Arabic numerals to cite material, e.g., ¹    The first reference used in a written document is listed as 1 in the reference list.
Where to place the superscript?  The superscript number ¹  is inserted into the document immediately next to the fact, concept, or quotation being cited.  If citing more than one reference at the same point, separate the numbers with commas and no spaces between. 
If a reference is used multiple times in one paper, use the same number throughout.
Using the author's names in-text: You may use author names in your text, as long as these mentions are accompanied by numbered citations. Use last names only.  For items with one or two authors, include both names. For items with 3 or more authors, include the first author's surname and then 'et al' or 'and colleagues'. Ex. Smith and Jones² reported on the questionnaire. Ex. Hammersmith et al³ reported on the survey.

Please use the American Medical Association (AMA) style:

1. O'Brien T, Barry FP. Stem cell therapy and regenerative medicine. Mayo Clin Proc. 2009;84(10):859-861. doi:10.1016/S0025-6196(11)60501-6.


2. Bandyopadhyay A, Wang L, Agyin J, et al. Doxorubicin in combination with a small TGFβ inhibitor: A potential novel therapy for metastatic breast cancer in mouse models. PLoS One. 2010;5(4). doi:10.1371/journal.pone.0010365.


3. Putra A, Ridwan FB, Putridewi AI, et al. The role of tnf-α induced mscs on suppressive inflammation by increasing tgf-β and il-10. Open Access Maced J Med Sci. 2018;6(10):1779-1783. doi:10.3889/oamjms.2018.404.

TABLES & FIGURES
Tables and figures should not be embedded in the text. Tables should be created in .doc or .docx  and cited consecutively in the text. To ensure the highest print quality, your figures must be submitted in .tif, .tiff, .jpg and .jpeg format with a minimum 300 dpi or higher resolutions. Captions/legends will be placed below figures and adjusted to 10 font size.

Templates can be accessed by link https://bit.ly/387GKv5